Siddha Drugs Prove Effective in Reducing Anaemia among Adolescent Girls: Study

A study published in IJTK reveals that Siddha drugs significantly reduce anaemia in adolescent girls. Conducted by the PHI-Public Health Initiative, the research involved 2,648 participants, showing improved haemoglobin levels and reduced anaemia symptoms. The study emphasizes Siddha medicine's potential in public health.

A recent study published in the Indian Journal of Traditional Knowledge (IJTK) by PHI-Public Health Initiative researchers asserts that Siddha drugs effectively reduce anaemia in adolescent girls, according to a Ministry of AYUSH press release.

Researchers from institutions such as the National Institute of Siddha (NIS), Ministry of Ayush; Xavier Research Foundation, Tamilnadu; and Velumailu Siddha Medical College and Hospital, Tamil Nadu, conducted the study. They found that the Siddha drug combination ABMN (Annapeticenturam, Bavana katukkay, Matulai manappaku, and Nellikkay lekiyam) improved haemoglobin levels, packed cell volume (PCV), mean corpuscular volume (MCV), and mean corpuscular haemoglobin (MCH) in anaemic adolescent girls.

The study included 2,648 girls, with 2,300 completing the 45-day program. Researchers conducted deworming treatment before administering the ABMN treatment. Clinical symptoms and various blood parameters were assessed before and after the treatment. The study showed significant reductions in anaemia symptoms and improvements in key blood markers, highlighting Siddha medicine's potential as a cost-effective, accessible public health treatment, noted Meenakumari, Director of the NIS.

(With inputs from agencies.)